Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Pembrolizumab and Concurrent Hypo-Fractionated Radiotherapy for Advanced Non-Resectable Cutaneous Squamous Cell Carcinoma

European Journal of Dermatology
Dermatology
2019English

Pembrolizumab Yields Lasting Merkel Cell Carcinoma Responses

Cancer Discovery
Oncology
2016English

Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature

Journal of Skin Cancer
DermatologyOncology
2012English

Talimogene Laherparepvec in Combination With Pembrolizumab Leads to a Complete Response in a Patient With Refractory Merkel Cell Carcinoma

JAAD Case Reports
Dermatology
2018English

Metastatic Pituitary Tumor From Renal Cell Carcinoma Treated by Fractionated Stereotactic Radiotherapy-Case Report-

Neurologia Medico-Chirurgica
SurgeryNeurology
2004English

PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2018English

Hypo- Or Conventionally Fractionated Radiotherapy Combined With Chemotherapy in Patients With Limited Stage Small Cell Lung Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

550 Efficacy and Toxicity of Hypofractionated Adjuvant Radiotherapy in Merkel Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Mo2 - Modelling Overall Survival in Immunotherapy Using Parametric Techniques: Avelumab in Previously Treated Metastatic Merkel Cell Carcinoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy